High frequency of germinal centre derivation in diffuse large B cell lymphoma from Asian patients

Journal of Clinical Pathology

Volumn 58, Issue 9, 2005, Pages 962-967

  Shia, A K H ^a   Gan, G G ^a   Jairaman, S ^a   Peh, S C ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; PROTEIN BCL 2; PROTEIN BCL 6; TRANSCRIPTION FACTOR E2F1;

ADOLESCENT; ADULT; AGED; ARTICLE; ASIAN; B CELL LYMPHOMA; FEMALE; FOLLICULAR LYMPHOMA; GENE REARRANGEMENT; GENE TRANSLOCATION; GERMINAL CENTER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 18; FEMALE; GENE REARRANGEMENT, B-LYMPHOCYTE; GENES, BCL-2; GERMINAL CENTER; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; TRANSLOCATION, GENETIC;

EID: 24644497276     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.022624     Document Type: Article

References (35)

1. Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Ann Oncol 1998;9:717-20.
2. Peh SC. Host ethnicity influences non-Hodgkin's lymphoma (NHL) subtype frequency and Epstein-Barr virus association rate: the experience of a multi-ethnic population in Malaysia. Histopathology 2001;38:456-8.
3. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994;84:1361-92.
4. Gatter KC, Warnke RA. Diffuse large B-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, et al, eds. World Health Organization classification of tumours, pathology and genetics of tumours of haematopoietic and lymphoid tissue. Lyon: IARC Press, 2001:171-4.
5. Alizadeh AA, Eisen MB, Davis ER, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-11.
6. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002;346:1937-47.
7. Hill ME, MacLennan KA, Cunningham DC, et al. Prognostic significance of BCL-2 expression and bcl-2 major breakpoint rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British national lymphoma investigation study. Blood 1996;88:1046-51.
8. Gascoyne RD, Adomat SA, Krajewski S, et al. Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. Blood 1997;90:244-51.
9. King BE, Chen C, Locker J, et al. Immunophenotypic and genotypic markers of follicular center cell neoplasia in diffuse large B-cell lymphomas. Mod Pathol 2000;13:1219-31.
10. Dalla-Favera R, Ye BH, Lo Coco F, et al. Identification of genetic lesions associated with diffuse large-cell lymphoma. Ann Oncol 1994;5:S55-60.
11. Meijerink PP. t(14;18), a journey to eternity. Leukemia 1997;11:2175-87.
12. Pezzella F, Tse AG, Cordell JL, et al. Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol 1990;137:225-32.
13. Barrons SL, Carter I, Owen RG, et al. Germinal center phenotype and bcl-2 expression combined with the international prognostic index improves patient risk stratification in diffuse large B-cell lymphoma. Blood 2002;99:1136-43.
14. Ree HJ, Yang WI, Kim CW, et al. Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma. Hum Pathol 2001;32:954-62.
15. Dogan A, Bagdi E, Munson P, et al. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas. Am J Surg Pathol 2000;24:846-52.
16. Almasri NM, Iturraspe JA, Braylan RC. CD10 expression in follicular lymphoma and large cell lymphoma is different from that of reactive lymph node follicles. Arch Pathol Lab Med 1998;122:539-44.
17. Pittaluga S, Ayoubi TAY, Wlodarska I, et al. BCL-6 expression in reactive lymphoid tissue and in B-cell non-Hodgkin's lymphomas. J Pathol 1996;179:145-50.
18. Migliazza A, Martinotti S, Chen W, et al. Frequent somatic hypermutation of the 5′ noncoding region of the BCL6 gene in B-cell lymphoma. Proc Natl Acad Sci U S A 1995;92:12520-4.
19. Wang X, Li Z, Naganuma A, et al. Negative autoregulation of BCL-6 is bypassed by genetic alterations in diffuse large B cell lymphomas. Proc Natl Acad Sci U S A 2002;99:15018-23.
20. Xu Y, McKenna RW, Molberg KH, et al. Clinicopathologic analysis of CD10+ and CD10- diffuse large B-cell lymphoma. Am J Clin Pathol 2001;116:183-90.
21. Lossos IS, Jones CD, Warnke R, et al. Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. Blood 2001;98:945-51.
22. Ohshima K, Kawasaki C, Muta K, et al. CD10 and Bcl10 expression in diffuse large B-cell lymphoma: CD10 is a marker for improved prognosis. Histopathology 2001;39:156-62.
23. Dyson N. The regulation of E2F by pRb-family proteins. Genes Dev 1998;12:2245-62.
24. Lai R, Medeiros L, Coupland R, et al. Immunohistochemical detection of E2F-1 in non-Hodgkin's lymphomas: a survey of 124 cases. Mod Pathol 1998;11:457-63
25. Zhang DX. Isolation of DNA from preserved specimens. In: lsaacson PG, Ingram DS, eds. Molecular tools for screening biodiversity 1998:41-5.
26. Gribben JG, Freedman A, Woo SD, et al. All advanced stage non-Hodgkin's Iymphomas with a polymerase chain reaction amplifiable breakpoint of Dcl-2 have residual cells containing a bcl-2 rearrangement at evaluation and after treatment Blood 1991;78:3275-80.
27. Huang JZ, Sanger WG, Greiner RC, et al. The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. Blood 2002;99:2285-90.
28. McCluggage WG, Catherwood M, Alexander HD, et al. Immunohistochemical expression of CD10 and t(14;18) chromosomal translocation may be indicators of follicle centre origin in nodal diffuse large B-cell lymphoma. Histopathology 2002;41:414-20.
29. Moller MB, Kania PW, Ino Y, et al. Frequent disruption of the RB1 pathway in diffuse larqe B cell lymphoma: prognostic significance of E2F-1 and p16INK4A. Leukemia 2000;14:898-904.
30. Kramer MHH, Hermans J, Wijburg E, et al. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood 1998;92:3152-62.
31. Skinnider BF, Horsman DE, Dupuis D, et al. Bcl-6 and Bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: correlation with 3q27 and 18q21 chromosomal abnormalities. Hum Pathol 1999;30:803-8.
32. Rantanen S, Monni O, Joensuu H, et al. Causes and consequences of BCL2 overexpression in diffuse large B-cell lymphoma. Leuk Lymphoma 2001;42:1089-98.
33. Barrans SL, O'Connor SJM, Evans PAS, et al. Rearrangement of the BCL6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B-cell lymphoma. Br J Haematol 2002;117:322-32.
34. Chan JA, Olvera M, Lai R, et al. Immunohistochemical expression of the transcription factor DP-1 and its heterodimeric partner E2F-1 in non-Hodgkin's lymphoma. Appl Immunohistochem Mol Morphol 2002;10:322-6.
35. McCluggage WG, Catherwood M, Alexander HD, ef at. Immunohistochemical expression of CD10 and t(14;18) chromosomal translocation may be indicators of follicle centre origin in nodal diffuse large B-cell lymphoma. Histopathology 2002;41:414-20.